One of Canada’s cannabis giants has revealed the new generation of cannabis products for the country’s legal marijuana market.

On Thursday (November 28), Canopy Growth (NYSE:CGC,TSX:WEED) unveiled its line-up of new wave cannabis products during an event dubbed “Flower Forward: The Future of Cannabis,” in which the company revealed the look of its new line of vape pens, infused beverages and chocolates.

At the event, marijuana enthusiasts got the chance to smell, taste and feel some of what so-called Cannabis 2.0 will have to offer.

The new product offerings indicate a shift for Canopy Growth from a cannabis firm to a tech company, Canopy Growth President Rade Kovacevic told the Investing News Network (INN), and the products give the company a chance to expand its existing market.

According to Kovacevic, the transition to 2.0 will represent an equal footing in the sales race between licensed producers (LPs) and the unregulated market in Canada.

“It’s the first time that the legal industry has had an opportunity to compete with the black market … while allowing us to create new products that we believe will disrupt not only the cannabis industry, but the beverage alcohol industry as well,” Kovacevic said.

The executive told INN the initial launch will present consumers with over 30 new products in the market. Additionally, the company is working on 20 more products for the 2.0 stage.

lines of canopy growth drink on a screen

A large portion of the new offerings is made up of the company’s beverage lines. There’s the Tweed Ready to Drink line that are pairs tonic, soda and ginger ale with some of Tweed’s most popular strains of marijuana.

There’s also two sparkling water lines, Houseplant and Quatreau, that offer up to 2.5 milligrams of tetrahydrocannabinol (THC) and well as a half-and-half option of 2 milligrams of (cannabidiol) CBD and 2 milligrams of THC.

hand taking pictures of canopy growth drinks

Finally, we have Deep Space, Canopy’s strongest beverage, with 10 milligrams of THC per can, the highest amount of the drug Health Canada allows per package. Deep Space will go for C$3.49 per can.

Canopy Growth is helped in the beverage arena by a C$5 billion investment from and a partnership with US-based alcohol maker Constellation Brands (NYSE:STZ).

line up of canopy growth drinks

As a part of this first pack of products, the LP is introducing new lines of vape pens, including the single-use Juju Joints and the reusable Juju Power, which comes with a USB docking station.

juju vape pen in its docking station

Its Juju line of vapes comes with an accompanying app that allows users to control temperatures remotely and track their device in case it gets lost.

image of the juju vape pen app capabilities

Juju Joints will range in price from C$44.99 to C$79.99 depending on the cartridge size, while the Juju Power will be C$34.99 and the accompanying cartridges will cost C$49.99.

tokyo smoke luma vape pens on display

Canopy Growth’s cannabis retailer, Tokyo Smoke, will also be adding a new line of branded vape pens called Luma. Along with the pens, Tokyo Smoke will offer color-coded cartridges with different strains of cannabis extracts at a variety of THC and CBD levels.

luma cartridges in small containers

Luma vapes will start at C$34.99, while the pods will run customers C$59.99.

The product release follows after the company announced it has received licensing from Health Canada for a state of the art beverage facility.

The third core product category Canopy Growth showcased included its brand new cannabis-infused chocolate lines for the Bean & Bud Craft Cannabis Company, it’s Tweed brand and Tokyo Smoke. The chocolates start at C$7.99 per bar and are made with cocoa harvested from countries including Colombia and the Dominican Republic.

canopy growth new chocolate offerings on a plate

“I think there’s opportunities to convert people from the illicit market to the legal markets through these products,” Kovacevic told INN. “You have products like our beverages … (that) don’t necessarily exist in the illicit market. And so I think they’re a great opportunity to bring new people into the sector.”

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Danielle Edwards, hold no direct investment interest in any company mentioned in this article.

The Investing News Network does not guarantee the accuracy or thoroughness of the information reported in the interviews it conducts. The opinions expressed in these interviews do not reflect the opinions of the Investing News Network and do not constitute investment advice. All readers are encouraged to perform their own due diligence.


Aurora Cannabis Inc. (“Aurora” or the “Company”) (NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today has announced today that it has entered into an agreement with a syndicate of underwriters led by BMO Capital Markets and ATB Capital Markets, under which the underwriters have agreed to buy on bought deal basis 12,000,000 units of the Company (the “Units”), at a price of US$10.45 per Unit for gross proceeds of approximately US$125 million (the “Offering”). Each Unit will be comprised of one common share of the Company (a “Common Share”) and one half of one common share purchase warrant of the Company (each full common share purchase warrant, a “Warrant”). Each Warrant will be exercisable to acquire one common share of the Company (a “Warrant Share”) for a period of 36 months following the closing date of the Offering at an exercise price of US$12.60 per Warrant Share, subject to adjustment in certain events.

Keep reading... Show less

Trading resumes in:

Company: Revive Therapeutics Ltd.

Keep reading... Show less


Revive Therapeutics Ltd. (” Revive ” or the ” Company “) (CSE:RVV) ( USA : RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that it has entered into an amended agreement with Canaccord Genuity Corp. and Leede Jones Gable Inc. as the co-lead underwriters (collectively, the ” Underwriters “), to increase the size of its previously announced offering of units (the ” Equity Units “) at a price of $0.50 per Equity Unit. Under the amended terms, the Underwriters have agreed to purchase, on a bought deal basis, 40,000,000 Equity Units for gross proceeds to the Company of $20,000,000 (the ” Offering “). The over-allotment option granted to the Underwriters will proportionately increase to 15% of the Offering.

Keep reading... Show less

The new dispensary brings expanded access for patients in the growing communities of Central Florida

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 77th nationwide. The new, 5,100 sq. ft. location marks the Company’s first in Summerfield expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”).

The Company announced today that its board of directors have approved a private placement of up to 15,000,000 units at a price of $.40 per unit for gross proceeds of up to $6,000,000. Each unit will consist of one common share of the Company and one share purchase warrant. Each share purchase warrant will be exercisable to purchase an additional common share at a fixed price of $.45 per share for a period of one year from closing.

Keep reading... Show less